- Home
- OLMA vs GEVO Comparison
OLMA vs GEVO Comparison
Compare OLMA & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- GEVO
- Stock Information
- Founded
- OLMA 2006
- GEVO 2005
- Country
- OLMA United States
- GEVO United States
- Employees
- OLMA N/A
- GEVO N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- GEVO Major Chemicals
- Sector
- OLMA Health Care
- GEVO Industrials
- Exchange
- OLMA Nasdaq
- GEVO Nasdaq
- Market Cap
- OLMA 299.7M
- GEVO 246.8M
- IPO Year
- OLMA 2020
- GEVO 2011
- Fundamental
- Price
- OLMA $4.65
- GEVO $1.49
- Analyst Decision
- OLMA Strong Buy
- GEVO Buy
- Analyst Count
- OLMA 4
- GEVO 2
- Target Price
- OLMA $24.50
- GEVO $7.58
- AVG Volume (30 Days)
- OLMA 825.6K
- GEVO 5.3M
- Earning Date
- OLMA 08-05-2025
- GEVO 08-07-2025
- Dividend Yield
- OLMA N/A
- GEVO N/A
- EPS Growth
- OLMA N/A
- GEVO N/A
- EPS
- OLMA N/A
- GEVO N/A
- Revenue
- OLMA N/A
- GEVO $42,034,000.00
- Revenue This Year
- OLMA N/A
- GEVO $1,022.79
- Revenue Next Year
- OLMA N/A
- GEVO $12.26
- P/E Ratio
- OLMA N/A
- GEVO N/A
- Revenue Growth
- OLMA N/A
- GEVO 145.38
- 52 Week Low
- OLMA $2.86
- GEVO $0.48
- 52 Week High
- OLMA $16.62
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- OLMA 52.46
- GEVO 58.73
- Support Level
- OLMA $4.38
- GEVO $1.17
- Resistance Level
- OLMA $5.01
- GEVO $1.50
- Average True Range (ATR)
- OLMA 0.30
- GEVO 0.10
- MACD
- OLMA 0.05
- GEVO 0.02
- Stochastic Oscillator
- OLMA 63.64
- GEVO 72.73
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.